이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Asia Vital Components 미래 성장

Future 기준 확인 6/6

Asia Vital Components (는) 각각 연간 28.2% 및 21.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 28.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 34% 로 예상됩니다.

주요 정보

28.2%

수익 성장률

28.2%

EPS 성장률

Tech 수익 성장	18.0%
매출 성장률	21.4%
향후 자기자본 수익률	34.0%
애널리스트 커버리지	Good
마지막 업데이트	26 Jun 2024

최근 미래 성장 업데이트

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Recent updates

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

May 29

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Mar 21

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Feb 26

Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?

Apr 23

Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?

Apr 08

Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 21

Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?

Feb 16

Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 01

Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?

Jan 17

Asia Vital Components (TPE:3017) Seems To Use Debt Quite Sensibly

Jan 02

Why Asia Vital Components Co., Ltd. (TPE:3017) Is A Dividend Rockstar

Dec 20

Is Now An Opportune Moment To Examine Asia Vital Components Co., Ltd. (TPE:3017)?

Dec 07

Is There More To The Story Than Asia Vital Components's (TPE:3017) Earnings Growth?

Nov 24

수익 및 매출 성장 예측

TWSE:3017 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (TWD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	110,867	12,509	11,812	15,812	5
12/31/2025	94,403	10,680	11,299	14,134	9
12/31/2024	71,739	7,512	7,726	11,218	10
3/31/2024	62,669	5,862	9,416	12,594	N/A
12/31/2023	59,194	5,305	6,556	10,324	N/A
9/30/2023	57,251	4,715	4,935	8,918	N/A
6/30/2023	56,365	4,528	3,682	8,120	N/A
3/31/2023	55,258	4,423	4,358	8,612	N/A
12/31/2022	56,017	4,162	5,135	8,840	N/A
9/30/2022	53,452	3,792	3,312	6,298	N/A
6/30/2022	50,342	3,407	2,133	4,482	N/A
3/31/2022	49,327	3,106	1,774	3,727	N/A
12/31/2021	47,333	2,901	1,213	2,841	N/A
9/30/2021	45,646	2,704	2,026	4,261	N/A
6/30/2021	43,922	2,490	2,364	4,768	N/A
3/31/2021	42,778	2,262	1,029	3,626	N/A
12/31/2020	39,666	1,916	2,404	4,870	N/A
9/30/2020	39,361	1,690	2,950	4,833	N/A
6/30/2020	39,228	1,308	1,491	3,318	N/A
3/31/2020	37,107	972	2,185	3,816	N/A
12/31/2019	36,534	958	757	2,458	N/A
9/30/2019	34,258	871	-648	971	N/A
6/30/2019	31,962	800	327	1,905	N/A
3/31/2019	29,482	747	274	1,719	N/A
12/31/2018	29,067	711	-723	971	N/A
9/30/2018	28,673	717	122	1,635	N/A
6/30/2018	27,873	776	-364	940	N/A
3/31/2018	27,178	811	259	1,609	N/A
12/31/2017	27,109	887	N/A	1,806	N/A
9/30/2017	26,750	930	N/A	1,684	N/A
6/30/2017	26,496	898	N/A	1,961	N/A
3/31/2017	26,528	869	N/A	1,230	N/A
12/31/2016	26,504	860	N/A	2,154	N/A
9/30/2016	26,040	826	N/A	3,340	N/A
6/30/2016	26,312	829	N/A	3,133	N/A
3/31/2016	26,194	797	N/A	3,080	N/A
12/31/2015	25,675	741	N/A	2,493	N/A
9/30/2015	25,023	681	N/A	1,124	N/A
6/30/2015	24,317	822	N/A	1,898	N/A
3/31/2015	24,336	820	N/A	2,021	N/A
12/31/2014	24,047	729	N/A	1,962	N/A
9/30/2014	23,739	640	N/A	2,369	N/A
6/30/2014	22,767	355	N/A	913	N/A
3/31/2014	21,397	282	N/A	1,984	N/A
12/31/2013	19,990	246	N/A	1,505	N/A
9/30/2013	18,976	204	N/A	1,119	N/A
6/30/2013	18,415	126	N/A	1,809	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 3017 의 연간 예상 수익 증가율( 28.2% )이 saving rate( 1% 보다 높습니다. ).

수익 vs 시장: 3017 의 연간 수익( 28.2% ) TW 시장( 17.8% 보다 빠르게 성장할 것으로 예상됩니다. 17.8% 연간).

고성장 수익: 3017 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 3017 의 수익(연간 21.4% ) TW 시장( 11.7% 보다 빠르게 성장할 것으로 예상됩니다. 11.7% 연간).

고성장 수익: 3017 의 수익(연간 21.4% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 3017 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 34 %)

Asia Vital Components 미래 성장

Future 기준 확인 6/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 8.6% to NT$824

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Price target increased by 8.3% to NT$506

Price target increased by 14% to NT$427

Recent updates

Dividend increased to NT$7.00

Investor sentiment improves as stock rises 19%

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

Price target increased by 8.6% to NT$824

Investor sentiment improves as stock rises 16%

We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Asia Vital Components Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Now 20% overvalued after recent price rise

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?

Investor sentiment improves as stock rises 15%

A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)

Now 20% overvalued after recent price rise

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Asia Vital Components Co., Ltd., Annual General Meeting, Jun 14, 2024

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 28% overvalued after recent price rise

Price target increased by 8.3% to NT$506

Investor sentiment improves as stock rises 15%

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Now 25% overvalued after recent price rise

Now 26% overvalued after recent price rise

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Now 24% undervalued after recent price drop

Price target increased by 14% to NT$427

Now 22% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improves as stock rises 22%

Upcoming dividend of NT$5.00 per share at 1.5% yield

Investor sentiment improves as stock rises 15%

Asia Vital Components Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023

Second quarter 2023 earnings released: EPS: NT$3.18 (vs NT$3.10 in 2Q 2022)

New major risk - Share price stability

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: NT$2.85 (vs NT$2.11 in 1Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 16%

Price target decreased by 13% to NT$108

Full year 2022 earnings released: EPS: NT$11.78 (vs NT$8.21 in FY 2021)

Price target decreased to NT$124

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Upcoming dividend of NT$4.30 per share

Second quarter 2022 earnings released: EPS: NT$3.10 (vs NT$2.25 in 2Q 2021)

Asia Vital Components Co., Ltd. Declares Dividend, Payable on September 20, 2022

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

Asia Vital Components Co., Ltd. Announces Board Changes

Asia Vital Components Co., Ltd. Announces Establishment of the ESG Committee of the Company

Asia Vital Components Co., Ltd. Announces to Shut Down Production Line on Floor

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$2.42 (vs NT$1.81 in 3Q 2020)

Price target increased to NT$102

Investor sentiment improved over the past week

Upcoming dividend of NT$2.80 per share

Second quarter 2021 earnings released: EPS NT$2.25 (vs NT$1.61 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$1.53 (vs NT$0.55 in 1Q 2020)

Investor sentiment deteriorated over the past week

Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?

Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?

Price target increased to NT$84.50